2020-12-28,BrainStorm Issues 2020 Letter to Shareholders
2020-12-18,BrainStorm Announces Completion of All Dosing in NurOwn® Phase 2 MS Study
2020-12-14,BrainStorm Announces NurOwn® Expanded Access Program
2020-12-08,Need To Know: Brainstorm Cell Therapeutics Inc. (NASDAQ:BCLI) Insiders Have Been Buying Shares
2020-11-26,Hedge Funds Arent Crazy About Brainstorm Cell Therapeutics Inc. (BCLI) Anymore
2020-11-23,BrainStorm to present NurOwn® Phase 3 Clinical Trial Results at 31st International Symposium on ALS/MND
2020-11-19,BCLI: Phase 3 ALS Trial Does Not Meet Primary Endpoint
2020-11-17,Why BrainStorm Cell Therapeutics Stock Imploded Today
2020-11-17,BrainStorm Announces Topline Results from NurOwn® Phase 3 ALS Study
2020-10-26,Rapid Reshore & Development and BrainStorm Cell Therapeutics Announce Agreement to Advance Construction of BrainStorm's U.S. Manufacturing Facility
2020-10-23,BCLI: Manufacturing Agreement with Catalent; Recent Sell-off Unwarranted
2020-10-22,Catalent and BrainStorm Cell Therapeutics Announce Partnership for the Manufacture of Mesenchymal Stem Cell Platform Therapy NurOwn®
2020-10-19,BrainStorm Announces Scientific Presentation of NurOwn® Exosome Preclinical ARDS Outcomes at the Virtual New York Stem Cell Foundation Conference
2020-10-16,BCLI: Phase 3 ALS Data Due Soon
2020-10-15,BrainStorm Announces Financial Results for the Third Quarter of 2020 and Provides a Corporate Update
2020-10-15,"Brainstorm Cell Therapeutics, Inc. to Host Earnings Call"
2020-10-12,BrainStorm to Present at the 2020 Cell & Gene Meeting on the Mesa
2020-10-09,How Much Of Brainstorm Cell Therapeutics Inc. (NASDAQ:BCLI) Do Insiders Own?
2020-10-02,BrainStorm Cell Therapeutics to Announce Third Quarter Financial Results and Provide a Corporate Update
2020-09-30,BrainStorm Announces Scientific Presentation at the Annual NEALS Meeting
2020-09-29,"BrainStorm Appoints William K. White as Senior Vice President, Head of Market Access & Pricing"
2020-09-16,Brainstorm Announces Grant of a New Japanese Patent for NurOwn®
2020-09-03,BrainStorm to Present at Scientific Conferences in September
2020-09-02,"BrainStorm Appoints Pharmaceutical Veteran Anthony Waclawski as Executive Vice President, Global Head of Regulatory Affairs"
2020-08-25,BrainStorm to Present Data Linking MRI Measures to Functional Improvement in Progressive Multiple Sclerosis (MS)
2020-08-19,"BrainStorm Announces Publication of New Preclinical Data Supporting Proposed NurOwn® Mechanism in ALS, Progressive MS and Alzheimer's Disease"
2020-08-10,We're Keeping An Eye On Brainstorm Cell Therapeutics' (NASDAQ:BCLI) Cash Burn Rate
2020-08-10,BrainStorm to Present at the 40th Annual Canaccord Genuity Growth Conference
2020-08-07,BCLI: Phase 3 ALS Data Expected by the End of November 2020
2020-08-05,BrainStorm Announces Financial Results for the Second Quarter of 2020 and Provides a Corporate Update
2020-07-27,BrainStorm Cell Therapeutics to Announce Second Quarter Financial Results and Provide a Corporate and R&D Update
2020-07-23,"5 Stock Gainers for Thursday: Smith & Wesson, Calix, Sunopta"
2020-07-23,BrainStorm Announces Groundbreaking Pre-Clinical Study of NurOwn® derived Exosome-Based Treatment for COVID-19 ARDS
2020-07-09,BCLI: KOL Event Gives Overview of the use of NurOwn® in Alzheimers Disease; Raising Valuation to $25/Share
2020-07-08,BrainStorm Hosting KOL Webinar to Discuss NurOwn® Phase 2 Alzheimer's Disease Program
2020-07-02,BrainStorm Announces Completion of All Dosing in NurOwn® Phase 3 Clinical Trial in ALS
2020-07-01,BrainStorm to Showcase Alzheimer's Disease Clinical Program in KOL Webinar
2020-06-25,"The Daily Biotech Pulse: Merck's Wonder Cancer Drug Snags Another Approval, Decision Day For Zogenix, UniQure Out-Licenses Gene Therapy"
2020-06-24,BrainStorm to study stem cell treatment in Alzheimer's patients
2020-06-24,BrainStorm Expands Clinical Pipeline to Evaluate NurOwn® for the Treatment of Alzheimer's Disease
2020-06-23,BrainStorm Cell Therapeutics to Join the Russell 2000® Index and Russell 3000® Index
2020-06-15,BrainStorm Granted SME Status by the European Medicines Agency
2020-06-11,BrainStorm to Present at the Raymond James Human Health Innovations Conference
2020-06-10,"BCLI: ALS Association and I AM ALS Awards $500,000 Grant; Potential Inclusion in Russell 3000 Index"
2020-06-09,"The ALS Association, I AM ALS Award BrainStorm Cell Therapeutics $500,000 for ALS Biomarker Study"
2020-06-04,Hedge Funds Warming Up To Brainstorm Cell Therapeutics Inc. (BCLI)
2020-06-03,BrainStorm to Participate in BIO Digital 2020
2020-06-02,BrainStorm Announces that Pivotal Phase 3 Trial Remains on Track for Topline Data in Q4-2020
2020-05-27,"BrainStorm Appoints Pharmaceutical Veteran Stacy R. Lindborg, Ph.D. as Executive Vice President, Head of Global Clinical Research"
2020-05-18,Does The Brainstorm Cell Therapeutics Inc. (NASDAQ:BCLI) Share Price Tend To Follow The Market?
2020-05-08,BCLI: The Countdown to Phase 3 ALS Data Begins
2020-05-07,BrainStorm Announces Financial Results for the First Quarter of 2020 and Provides a Corporate Update
2020-05-07,BrainStorm Leases a New Cleanroom Facility at The Tel Aviv Sourasky Medical Center to Manufacture NurOwn® for The European Union
2020-05-04,BrainStorm Presents New Data Highlighting NurOwn® Immunomodulation in Neurology
2020-04-29,BrainStorm-Cell Therapeutics to Announce First Quarter Financial Results and Provide a Corporate Update
2020-04-08,BCLI: $1.5M Grant from Israel Innovation Authority
2020-04-03,BrainStorm Awarded $1.5 Million Non-Dilutive Grant for 2020 by the Israel Innovation Authority
2020-04-01,David Setboun Joins BrainStorm as Executive Vice President and Chief Operating Officer
2020-03-31,"BrainStorm Appoints Renowned Distinguished Economist, Prof. Jacob Frenkel, Chairman of the Board of Directors"
2020-03-16,BrainStorm to Hold a Conference Call to Update Investors on Corporate Steps Taken to Address COVID-19
2020-03-06,BrainStorm Cell Therapeutics Raises $10.0 Million in Common Stock Sale at $8.00 Per Share
2020-02-27,Fifth and Final Site Announced for BrainStorms Progressive Multiple Sclerosis Phase 2 Clinical Trial
2020-02-20,BCLI: Phase 3 ALS Results in 4Q20
2020-02-18,"BrainStorm Announces Operational Highlights and Financial Results for the Year Ended December 31, 2019"
2020-02-18,"Brainstorm Cell Therapeutics, Inc. to Host Earnings Call"
2020-02-17,BrainStorms Chief Operating Officer to Present at Noble Capital Markets Sixteenth Annual Investor Conference
2020-02-11,BrainStorm Cell Therapeutics and FDA Agree to Potential NurOwn® Regulatory Pathway for Approval in ALS
2020-02-10,BrainStorm Cell Therapeutics to Announce Fourth Quarter and Full Year 2019 Financial Results and Provide a Corporate Update
2020-02-04,BrainStorm CEO to Provide Company Update at the BIO CEO & Investor Conference
2020-01-29,BrainStorm Receives Notice of Intention to Grant Additional EU patent for NurOwn®
2020-01-21,"BrainStorm Cell Therapeutics COO and CMO, Dr. Ralph Kern, to Present at the 10th Annual California ALS Research Summit"
2020-01-17,"How Many Brainstorm Cell Therapeutics Inc. (NASDAQ:BCLI) Shares Did Insiders Buy, In The Last Year?"
2020-01-07,BrainStorm Cell Therapeutics to Present at the 2020 Biotech Showcase and 3rd Annual Neuroscience Innovation Forum at JPM Week
2020-01-03,Weekly CFO Buys Highlight
2019-12-19,NurOwn® Data Safety Monitoring Board Recommends MS Phase 2 Clinical Trial Continue
2019-12-18,BrainStorm Issues 2019 Letter to Shareholders
2019-12-11,BrainStorm Selected as Buzz of BIO 2020 Winner
2019-11-26,BrainStorm Cell Therapeutics to make scientific presentations at the 30th International Symposium on ALS/MND
2019-11-25,BrainStorm Announces the Mount Sinai Medical Center as a Progressive MS Phase 2 Clinical Trial Site
2019-11-21,BCLI: Phase 3 ALS Trial Fully Enrolled; Phase 2 Results Published in Neurology
2019-11-20,BrainStorm Cell Therapeutics Announces Publication of NurOwn® ALS Phase 2 Randomized Clinical Trial Data in Neurology
2019-11-18,Does Brainstorm Cell Therapeutics Inc. (NASDAQ:BCLI) Have A High Beta?
2019-11-14,"The Daily Biotech Pulse: Amarin Braces For Vascepa Adcom Verdict, Biotechs On A Fundraising Spree, Zosano Makes Progress With Migraine Drug Filing"
2019-11-14,BrainStorm Cell Therapeutics Announces Research Grant Award From the National Multiple Sclerosis Society
2019-11-14,BrainStorm Announces Financial Results for the Third Quarter of 2019 and Provides a Corporate Update
2019-11-13,BrainStorm Announces Grant of a New Japanese Patent for NurOwn®
2019-11-12,BrainStorm Cell Therapeutics Announces Ralph Kern MD MHSc to Present at the 7th International Stem Cell Meeting
2019-11-05,BrainStorm Cell Therapeutics to Announce Third Quarter Financial Results and Provide a Comprehensive Corporate Update
2019-10-28,NurOwn® Data Safety Monitoring Board Recommends ALS Phase 3 Clinical Trial Continue
2019-10-25,BrainStorm Cell Therapeutics to Present at the Dawson James Securities 5th Annual Small Cap Growth Conference
2019-10-24,BrainStorm Cell Therapeutics President and CEO to be Featured as Keynote Speaker at Cell Series UK 2019
2019-10-23,BrainStorm Cell Therapeutics Presentations at Neuromuscular Drug Development Summit
2019-10-11,BrainStorms NurOwn® Phase 3 ALS Clinical Trial Now Fully Enrolled
2019-10-07,BrainStorm Announces Notice of US Patent Allowance for NurOwn® Cellular Therapeutic Technology Platform
2019-10-02,BrainStorm Cell Therapeutics to Present NurOwn® Phase 2 Biomarker Data at North East Amyotrophic Lateral Sclerosis (NEALS) 18th Annual Meeting
2019-09-27,BrainStorm Cell Therapeutics Announces Support for FDA Guidelines on ALS Drug Development
2019-09-19,Is Brainstorm Cell Therapeutics Inc. (NASDAQ:BCLI) Growing Too Fast?
2019-09-09,"BrainStorm Strengthens Senior Executive Management Team with the Appointment of Preetam Shah, Ph.D., M.B.A., as Chief Financial Officer"
2019-09-06,BrainStorm Cell Therapeutics to Present Late Breaking News ePoster at the 35th ECTRIMS Congress
2019-08-16,BCLI: 170 Patients Enrolled in Phase 3 ALS Trial
